Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 64 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT02569879
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Aspergillosis, +23 more
- Locations
-
- GSK Investigational Site Bogotá, Colombia
NCT01568060
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +25 more
- Locations
-
- GSK Investigational Site Seoul, South Korea
NCT01358825
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Morvik, Norway
- GSK Investigational Site Oslo, Norway
- GSK Investigational Site Örebro, Sweden
- GSK Investigational Site Umeå, Sweden
NCT01453998
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Santo Domingo, Dominican Republic
- GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site Mesa, Arizona, United States
- GSK Investigational Site Mesa, Arizona, United States
NCT00148941
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Antioch, California, United States
- GSK Investigational Site Daly City, California, United States
- GSK Investigational Site Fairfield, California, United States
NCT01171989
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
NCT01577732
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Haiphong, Vietnam
NCT02853929
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
- Locations
-
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
NCT00352963
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
- Locations
-
- GSK Investigational Site Alcorcón, Spain
- GSK Investigational Site Almeira, Spain
- GSK Investigational Site Badalona, Spain
- GSK Investigational Site Barcelona, Spain
Completed
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site DeLand, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
NCT00970307
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
Completed
Post Market Surveillance for Infanrix™
NCT00908115
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Daegu, South Korea
NCT00463437
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
- Locations
-
- GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
NCT01353703
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Belgaun, India
- GSK Investigational Site Chennai, India
- GSK Investigational Site Pune, India
- GSK Investigational Site Pune, India
NCT00325156
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Singapore
NCT00753649
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Vancouver, British Columbia, Canada
- GSK Investigational Site Truro, Nova Scotia, Canada
NCT01309646
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Daegu, South Korea
- GSK Investigational Site Goyang, South Korea
- GSK Investigational Site GyeongSangNam-do, South Korea
- GSK Investigational Site Iksan, South Korea
NCT02096263
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Fayetteville, Arkansas, United States
- GSK Investigational Site Anaheim, California, United States
- GSK Investigational Site Daly City, California, United States